C4 THERAPEUTICS INC. - COMMON STOCK
4.2500
22-十一月-24 15:44:58
15 分钟延时
股票
+0.2400
+5.99%
今日范围
3.9100 - 4.3385
ISIN
N/A
来源
NASDAQ
-
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
04 5月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
19 4月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
23 2月 2023 06:00:02 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Two Virtual February 2023 Conferences
08 2月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
30 1月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
09 1月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 1月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
03 11月 2022 06:00:02 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022
26 9月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
04 8月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
02 8月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
05 5月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
08 4月 2022 12:00:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
16 3月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
09 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
08 3月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights
24 2月 2022 06:00:03 条件 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
10 1月 2022 06:00:02 条件 Nasdaq GlobeNewswire